Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Graft-Versus-Host Disease
Ernst Holler, Hildegard Greinix, Robert Zeiser
Springer eBooks (2018), pp. 323-330
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser, et al.
The Lancet Haematology (2019) Vol. 6, Iss. 3, pp. e132-e143
Open Access | Times Cited: 249
Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Goda Daugėlaitė, Kristė Užkuraitytė, Eglė Jagelavičienė, et al.
Medicina (2019) Vol. 55, Iss. 2, pp. 25-25
Open Access | Times Cited: 153
Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites
David Michonneau, Eleonora Latis, Emmanuel Curis, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 110
Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells
Weijiang Liu, Na Zhou, Yuanlin Liu, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Biomarkers for Allogeneic HCT Outcomes
Djamilatou Adom, Courtney M. Rowan, Titilayo Adeniyan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 38
Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
Harald Wajant, Andreas Beilhack
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 32
Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
Yanmin Zhao, Jimin Shi, Yi Luo, et al.
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 5, pp. e128-e133
Open Access | Times Cited: 31
Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments
Martin Krenn, Anna Grisold, Philipp Wohlfarth, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 24
Biomarkers for acute and chronic graft versus host disease: state of the art
Luisa Giaccone, Danilo Faraci, Sara Butera, et al.
Expert Review of Hematology (2020) Vol. 14, Iss. 1, pp. 79-96
Open Access | Times Cited: 20
Established and Emerging Treatments of Skin GvHD
Cornelia S. Link, Katja Sockel, Catharina Schuetz
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
PET assessment of acute gastrointestinal graft versus host disease
Ashleigh Scott, Andrea S. Henden, Glen Kennedy, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 9, pp. 973-979
Open Access | Times Cited: 6
Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma—Romanian Experience
Alina Tănase, Andrei Coliță, Oana Gabriela Craciun, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2417-2417
Open Access | Times Cited: 15
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
Eva M. Weissinger, Jochen Metzger, Michael Schleuning, et al.
Leukemia (2020) Vol. 35, Iss. 6, pp. 1763-1772
Open Access | Times Cited: 15
Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
Balaji Balakrishnan, Uday Kulkarni, Aswin Anand Pai, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Outcome of Second Allogeneic HSCT for Patients with Inborn Errors of Immunity: Retrospective Study of 20 Years’ Experience
Priti J Mehta, Christo Tsilifis, Su Han Lum, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 8, pp. 1812-1826
Closed Access | Times Cited: 4
Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation
B. Valatkaite‐Rakstiene, Rita Čekauskienė, Tadas Žvirblis, et al.
International Journal of Immunogenetics (2024) Vol. 51, Iss. 2, pp. 63-71
Closed Access | Times Cited: 1
Acute Graft versus Host Disease in Beta Thalassemia Patients Following Allogeneic Haematopoietic Stem Cell Transplantation
Nabila Rafique, Ali Asghar, Tariq Ghaffor, et al.
Journal of College of Physicians And Surgeons Pakistan (2024) Vol. 34, Iss. 04, pp. 480-483
Open Access | Times Cited: 1
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation
Felipe Bueno, Eliseo Albert, José Luís Piñana, et al.
Transplant Infectious Disease (2020) Vol. 23, Iss. 3
Closed Access | Times Cited: 10
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells
Ming Ni, Lei Wang, Yuntian Ding, et al.
Cytotherapy (2021) Vol. 24, Iss. 3, pp. 311-319
Closed Access | Times Cited: 9
Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease
Deborah S. Hooker, Kristin Grabe-Heyne, Christof Henne, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 11, pp. 929-939
Open Access | Times Cited: 8
Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Nutritional Status and Intake in Children
Janne Anita Kvammen, Rut Anne Thomassen, Jochen Buechner, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 75, Iss. 5, pp. 675-682
Open Access | Times Cited: 6
Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typing
Wiebke Stenger, Annette Künkele, Matthias Niemann, et al.
Pediatric Blood & Cancer (2019) Vol. 67, Iss. 3
Open Access | Times Cited: 8
Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation
Paola Pérez, Jaime Patiño, A. Franco, et al.
Blood Research (2022) Vol. 57, Iss. 1, pp. 34-40
Open Access | Times Cited: 5
A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation
Katharina Och, Amin T. Turki, Katharina M. Götz, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease
Anand Srinivasan, Sandra Bajaña, Aneta Pankow, et al.
BMC Immunology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top